{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Management of Seizures in Brain Tumor Patients

Purpose of Activity

To provide registered professional nurses with current guidelines and research findings on the use of antiepileptic drugs (AEDs) and the risk of seizures in brain tumor patients.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe seizure risk for brain tumor patients and recommended use of prophylactic AEDs.
  2. Discuss drug therapy with AEDs and its complications.
  3. Discuss research findings and their implications for management of the patient.
Price: $27.95


  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Test Code: JNN0110
Published: February 2010
Expires: 12/6/2019
Collections: Brain Tumor
Passing Score: 13/18 (72%)
Authors: Kristen Catherine Smith
Categories: Neurological , Oncology